432 related articles for article (PubMed ID: 30802734)
21. Differential access to syringe exchange and other prevention activities among people who inject drugs in rural and urban areas of Puerto Rico.
Welch-Lazoritz M; Habecker P; Dombrowski K; Rivera Villegas A; Davila CA; Rolón Colón Y; Miranda De León S
Int J Drug Policy; 2017 May; 43():16-22. PubMed ID: 28160735
[TBL] [Abstract][Full Text] [Related]
22. Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996-2015.
Graham S; Maher L; Wand H; Doyle M; Iversen J
Int J Drug Policy; 2017 Sep; 47():69-76. PubMed ID: 28735774
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials.
van Santen DK; Lodi S; Dietze P; van den Boom W; Hayashi K; Dong H; Cui Z; Maher L; Hickman M; Boyd A; Prins M
Addiction; 2023 Jun; 118(6):1116-1126. PubMed ID: 36710474
[TBL] [Abstract][Full Text] [Related]
24. Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020.
Tookes HE; Bartholomew TS; Sugar SES; Plesons MD; Bluthenthal RN; Wenger LD; Patel SV; Kral AH; Lambdin BH
Int J Drug Policy; 2024 Jan; 123():104289. PubMed ID: 38071932
[TBL] [Abstract][Full Text] [Related]
25. Frequency of injecting among people who inject drugs: A systematic review and meta-analysis.
Colledge S; Leung J; Larney S; Peacock A; Grebely J; Hickman M; Cunningham E; Trickey A; Stone J; Vickerman P; Degenhardt L
Int J Drug Policy; 2020 Feb; 76():102619. PubMed ID: 31864107
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
[TBL] [Abstract][Full Text] [Related]
27. Syringe Coverage Among People Who Inject Drugs in West Virginia, USA.
Allen ST; White RH; O'Rourke A; Schneider KE; Weir BW; Lucas GM; Kilkenny ME; Sherman SG
AIDS Behav; 2021 Oct; 25(10):3377-3385. PubMed ID: 33886011
[TBL] [Abstract][Full Text] [Related]
28. Harm reduction product distribution in British Columbia.
Harvard SS; Hill WD; Buxton JA
Can J Public Health; 2008; 99(6):446-50. PubMed ID: 19149383
[TBL] [Abstract][Full Text] [Related]
29. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy.
Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L
Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and correlates of receptive syringe-sharing among people who inject drugs in rural Appalachia.
White RH; O'Rourke A; Kilkenny ME; Schneider KE; Weir BW; Grieb SM; Sherman SG; Allen ST
Addiction; 2021 Feb; 116(2):328-336. PubMed ID: 32533612
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus prevalence and associated risk factors among Indigenous Australians who inject drugs.
Doyle M; Maher L; Graham S; Wand H; Iversen J
Aust N Z J Public Health; 2018 Feb; 42(1):52-56. PubMed ID: 29168317
[TBL] [Abstract][Full Text] [Related]
32. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
[TBL] [Abstract][Full Text] [Related]
33. Syringe disposal among people who inject drugs before and after the implementation of a syringe services program.
Levine H; Bartholomew TS; Rea-Wilson V; Onugha J; Arriola DJ; Cardenas G; Forrest DW; Kral AH; Metsch LR; Spencer E; Tookes H
Drug Alcohol Depend; 2019 Sep; 202():13-17. PubMed ID: 31280002
[TBL] [Abstract][Full Text] [Related]
34. Estimating the number of people who inject drugs in Australia.
Larney S; Hickman M; Guy R; Grebely J; Dore GJ; Gray RT; Day CA; Kimber J; Degenhardt L
BMC Public Health; 2017 Sep; 17(1):757. PubMed ID: 28962604
[TBL] [Abstract][Full Text] [Related]
35. Correlates of sharing of needles and syringes among people who inject drugs in Dhaka city, Bangladesh.
Hemel MM; Reza MM; Shafiq TK; Kabir MI; Rana AM; Khan SI
J Infect Dev Ctries; 2021 Oct; 15(10):1497-1506. PubMed ID: 34780373
[TBL] [Abstract][Full Text] [Related]
36. Individual-level needle and syringe coverage in Melbourne, Australia: a longitudinal, descriptive analysis.
O'Keefe D; Scott N; Aitken C; Dietze P
BMC Health Serv Res; 2016 Aug; 16(1):411. PubMed ID: 27542604
[TBL] [Abstract][Full Text] [Related]
37. Should sterile needle and syringe wastage be included within individual-level needle and syringe coverage measures?
Daniel O; Campbell A; Paul D
Int J Drug Policy; 2018 Oct; 60():8-9. PubMed ID: 30077904
[No Abstract] [Full Text] [Related]
38. Injection partnership characteristics and HCV status associations with syringe and equipment sharing among people who inject drugs.
Mackesy-Amiti ME; Boodram B; Page K; Latkin C
BMC Public Health; 2023 Jun; 23(1):1191. PubMed ID: 37340398
[TBL] [Abstract][Full Text] [Related]
39. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review.
Colledge-Frisby S; Ottaviano S; Webb P; Grebely J; Wheeler A; Cunningham EB; Hajarizadeh B; Leung J; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Degenhardt L
Lancet Glob Health; 2023 May; 11(5):e673-e683. PubMed ID: 36996860
[TBL] [Abstract][Full Text] [Related]
40. Factors Associated with Sterile Syringe Acquisition among People Who Inject Drugs in West Virginia.
Allen ST; Mazhnaya A; O'Rourke A; White RH; Wedlock P; Grieb SM; Kilkenny ME; Walls M; Sherman SG
Subst Use Misuse; 2021; 56(12):1776-1784. PubMed ID: 34311667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
